Terazosin is used for: Hypertension; Benign prostatic hyperplasia.
Recorded in the NepalDoc medicine catalog for Terazosin.
Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP.
From the U.S. FDA-approved label for Terazosin. Full label: DailyMed.
Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP. The long-term effects of terazosin capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules, USP can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
From the U.S. FDA-approved label for Terazosin. Full label: DailyMed.
If terazosin capsules administration is discontinued for several days, therapy should be reinstituted using the initial dosing regimen. Patients should be closely followed during initial administration in order to minimize the risk of severe hypotensive response. Subsequent Doses The dose should be increased in a stepwise fashion to 2 mg, 5 mg, or 10 mg once daily to achieve the desired improvement of symptoms and/or flow rates.
Directions from the U.S. FDA-approved label for Terazosin — your doctor or pharmacist may advise differently.
Terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.
Excerpt from the U.S. FDA-approved label for Terazosin. Talk to a pharmacist or doctor before use.
Syncope and “First-dose” Effect Terazosin capsules, like other alpha-adrenergic blocking agents, can cause marked lowering of blood pressure, especially postural hypotension, and syncope in association with the first dose or first few days of therapy. A similar effect can be anticipated if therapy is interrupted for several days and then restarted. Syncope has also been reported with other alpha-adrenergic blocking agents in association with rapid dosage increases or the introduction of another antihypertensive drug.
Warnings and precautions excerpt from the U.S. FDA-approved label for Terazosin — not a complete list. Talk to a pharmacist or doctor before use.
Benign Prostatic Hyperplasia The incidence of treatment-emergent adverse events has been ascertained from clinical trials conducted worldwide. All adverse events reported during these trials were recorded as adverse reactions. The incidence rates presented below are based on combined data from six placebo-controlled trials involving once-a-day administration of terazosin capsules at doses ranging from 1 to 20 mg.
Excerpt from the U.S. FDA-approved label for Terazosin — not a complete list. Talk to a pharmacist or doctor about side effects.
10 brands · 4 makers in the NepalDoc catalog — see the full Terazosin guide →
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Storage information from the U.S. FDA-approved label for Terazosin.
What is Terapress?
Terapress 2mg Tablet is a Terazosin medicine made by Intas Pharmaceuticals Ltd. It comes as 2mg Tablet.
What is Terapress used for?
Terazosin is used for Hypertension, Benign prostatic hyperplasia.
What is the generic name of Terapress?
The generic name of Terapress is Terazosin.
Which brands of Terazosin are available in Nepal?
10 brands of Terazosin are listed in the NepalDoc catalog, from 4 makers — including Hytrin 1mg Tablet, Hytrin 2mg Tablet, Hytrin 5mg Tablet, Teralfa 1mg Tablet, Teralfa 2mg Tablet, Terapress 1mg Tablet.
What are the side effects of Terazosin?
Benign Prostatic Hyperplasia The incidence of treatment-emergent adverse events has been ascertained from clinical trials conducted worldwide. All adverse events reported during these trials were recorded as adverse reactions.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
